VBA
PRVA icon

Van Berkom & Associates’s Privia Health PRVA Stock Holding History

Van Berkom & Associates’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$83.4M Buy
4,053,043
+208,787
+5% +$4.71M 2.71% 8
2025
Q4 		$91.1M Buy
3,844,256
+69,691
+2% +$1.7M 2.63% 10
2025
Q3 		$94M Buy
3,774,565
+873,344
+30% +$18.8M 2.72% 8
2025
Q2 		$66.7M Buy
2,901,221
+887,549
+44% +$20.6M 1.99% 33
2025
Q1 		$45.2M Buy
+2,013,672
New +$46.8M 1.45% 38

Other funds holding PRVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Van Berkom & Associates's PRVA Position: Q1 2026 in Review

Van Berkom & Associates increased its Privia Health (PRVA) stake by 5.4% in Q1 2026, buying an estimated $4.71M and bringing the position to 4,053,043 shares worth $83.4M. The position accounts for 2.71% of the portfolio, ranked #8.

Van Berkom & Associates first reported a position in PRVA in Q1 2025 and has held it in 5 quarters since. The position peaked at $94M in Q3 2025. 293 funds tracked by Wall St. Rank hold PRVA as of Q1 2026.

  • Van Berkom & Associates held 4,053,043 shares of Privia Health worth $83.4M as of Q1 2026.
  • Van Berkom & Associates bought 208,787 Privia Health shares in Q1 2026, an estimated $4.71M.
  • Privia Health made up 2.71% of Van Berkom & Associates's portfolio in Q1 2026, its #8 holding.
  • Van Berkom & Associates first reported a position in Privia Health in Q1 2025 and has held it in 5 quarters since.
  • Van Berkom & Associates's Privia Health position peaked at $94M in Q3 2025.
  • 293 funds tracked by Wall St. Rank held Privia Health as of Q1 2026.

Based on Van Berkom & Associates's 13F filing for Q1 2026, filed 7 May 2026.